A PHARMACOKINETIC STUDY TO ASSESS THE INFLUENCE OF SIMULTANEOUS CYP3A4 AND P-GLYCOPROTEIN INHIBITION ON E7080 PHARMACOKINETICS FOLLOWING SINGLE DOSE ORAL ADMINISTRATION OF 5 MG E7080 TO HEALTHY VOLUNTEERS: